The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online October 14, 2009
The Journal of Immunology, 2009, 183, 5526 -5536
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803663

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jimmunol.0803663v1
183/9/5526    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hearn, A.
Right arrow Articles by Rock, K. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hearn, A.
Right arrow Articles by Rock, K. L.

The Specificity of Trimming of MHC Class I-Presented Peptides in the Endoplasmic Reticulum1

Arron Hearn,* Ian A. York,{dagger} and Kenneth L. Rock2*

*Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01655; and {dagger}Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824

Aminopeptidases in the endoplasmic reticulum (ER) can cleave antigenic peptides and in so doing either create or destroy MHC class I-presented epitopes. However, the specificity of this trimming process overall and of the major ER aminopeptidase ERAP1 in particular is not well understood. This issue is important because peptide trimming influences the magnitude and specificity of CD8 T cell responses. By systematically varying the N-terminal flanking sequences of peptides in a cell-free biochemical system and in intact cells, we elucidated the specificity of ERAP1 and of ER trimming overall. ERAP1 can cleave after many amino acids on the N terminus of epitope precursors but does so at markedly different rates. The specificity seen with purified ERAP1 is similar to that observed for trimming and presentation of epitopes in the ER of intact cells. We define N-terminal sequences that are favorable or unfavorable for Ag presentation in ways that are independent from the epitopes core sequence. When databases of known presented peptides were analyzed, the residues that were preferred for the trimming of model peptide precursors were found to be overrepresented in N-terminal flanking sequences of epitopes generally. These data define key determinants in the specificity of Ag processing.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the National Institutes of Health (to K.L.R.) and core resources supported by the Diabetes Endocrinology Research Center Grant.

2 Address correspondence and reprint requests to Dr. Kenneth L. Rock, Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01655. E-mail address: Kenneth.Rock{at}umassmed.edu

3 Abbreviations used in this paper: MHC I, MHC class I; ER, endoplasmic reticulum; ERAP1, endoplasmic reticulum aminopeptidase 1; MFI, mean fluorescence intensity; siRNA, small interfering RNA.

4 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.